Literature DB >> 20124115

Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia.

Harry Pantazopoulos1, Tsung-Ung W Woo, Maribel P Lim, Nicholas Lange, Sabina Berretta.   

Abstract

CONTEXT: Chondroitin sulfate proteoglycans (CSPGs), a main component of the brain extracellular matrix, regulate developmental and adult neural functions that are highly relevant to the pathogenesis of schizophrenia. Such functions, together with marked expression of CSPGs in astrocytes within the normal human amygdala and evidence of a disruption of astrocytic functions in this disease, point to involvement of CSPG-glial interactions in schizophrenia. HYPOTHESIS: Chondroitin sulfate proteoglycan-related abnormalities involve glial cells and extracellular matrix pericellular aggregates (perineuronal nets) in the amygdala and entorhinal cortex of subjects with schizophrenia.
DESIGN: Postmortem case-control study.
SETTING: The Translational Neuroscience Laboratory at McLean Hospital, Harvard Medical School. Specimens were obtained from the Harvard Brain Tissue Resource Center at McLean Hospital. PARTICIPANTS: Two separate cohorts of healthy control (n = 15; n = 10) and schizophrenic (n = 11; n = 10) subjects and a cohort of subjects with bipolar disorder (n = 11).
INTERVENTIONS: Quantitative, immunocytological, and histological postmortem investigations. MAIN OUTCOME MEASURES: Numerical densities of CSPG-positive glial cells and perineuronal nets, glial fibrillary acidic protein-positive astrocytes, and total numbers of parvalbumin-positive neurons in the deep amygdala nuclei and entorhinal cortex.
RESULTS: In schizophrenia, massive increases in CSPG-positive glial cells were detected in the deep amygdala nuclei (419%-1162%) and entorhinal cortex (layer II; 480%-1560%). Perineuronal nets were reduced in the lateral nucleus of the amygdala and lateral entorhinal cortex (layer II). Numerical densities of glial fibrillary acidic protein-positive glial cells and total numbers of parvalbumin-positive neurons were unaltered. Changes in CSPG-positive elements were negligible in subjects with bipolar disorder.
CONCLUSIONS: Marked changes in functionally relevant molecules in schizophrenia point to a pivotal role for extracellular matrix-glial interactions in the pathogenesis of this disease. Disruption of these interactions, unsuspected thus far, may represent a unifying factor contributing to disturbances of neuronal migration, synaptic connectivity, and GABAergic, glutamatergic, and dopaminergic neurotransmission in schizophrenia. The lack of CSPG abnormalities in bipolar disorder points to a distinctive aspect of the pathophysiology of schizophrenia in key medial temporal lobe regions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124115      PMCID: PMC4208310          DOI: 10.1001/archgenpsychiatry.2009.196

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  68 in total

1.  Wisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons.

Authors:  W Härtig; K Brauer; G Brückner
Journal:  Neuroreport       Date:  1992-10       Impact factor: 1.837

2.  Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics.

Authors:  B Pakkenberg
Journal:  Arch Gen Psychiatry       Date:  1990-11

3.  Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone.

Authors:  A T Beggah; M T Dours-Zimmermann; F M Barras; A Brosius; D R Zimmermann; A D Zurn
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

4.  The human amygdaloid complex: a cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining.

Authors:  K S Sims; R S Williams
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

5.  Th1, Th2 and Th3 cytokine alteration in schizophrenia.

Authors:  Yong-Ku Kim; Aye-Mu Myint; Bun-Hee Lee; Chang-Su Han; Heon-Jeong Lee; Dae-Jin Kim; Brian E Leonard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-11       Impact factor: 5.067

6.  Diagnostic criteria for use in psychiatric research.

Authors:  J P Feighner; E Robins; S B Guze; R A Woodruff; G Winokur; R Munoz
Journal:  Arch Gen Psychiatry       Date:  1972-01

7.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia.

Authors:  S E Arnold; B T Hyman; G W Van Hoesen; A R Damasio
Journal:  Arch Gen Psychiatry       Date:  1991-07

Review 8.  Emerging roles for TGF-beta1 in nervous system development.

Authors:  Flávia Carvalho Alcantara Gomes; Vivian de Oliveira Sousa; Luciana Romão
Journal:  Int J Dev Neurosci       Date:  2005-08       Impact factor: 2.457

9.  Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain.

Authors:  G Brückner; K Brauer; W Härtig; J R Wolff; M J Rickmann; A Derouiche; B Delpech; N Girard; W H Oertel; A Reichenbach
Journal:  Glia       Date:  1993-07       Impact factor: 7.452

10.  Selective cytochemical demonstration of glycoconjugate-containing terminal N-acetylgalactosamine on some brain neurons.

Authors:  F Nakagawa; B A Schulte; S S Spicer
Journal:  J Comp Neurol       Date:  1986-01-08       Impact factor: 3.215

View more
  112 in total

1.  Increased extracellular clusterin in the prefrontal cortex in schizophrenia.

Authors:  Katina M Athanas; Sarah L Mauney; Tsung-Ung W Woo
Journal:  Schizophr Res       Date:  2015-10-21       Impact factor: 4.939

2.  Effects of haloperidol and clozapine on synapse-related gene expression in specific brain regions of male rats.

Authors:  Martina von Wilmsdorff; Fabian Manthey; Marie-Luise Bouvier; Oliver Staehlin; Peter Falkai; Eva Meisenzahl-Lechner; Andrea Schmitt; Peter J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-05       Impact factor: 5.270

3.  Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis.

Authors:  Enrico Cocchi; Antonio Drago; Alessandro Serretti
Journal:  Mol Neurobiol       Date:  2015-04-24       Impact factor: 5.590

4.  Normal Development of the Perineuronal Net in Humans; In Patients with and without Epilepsy.

Authors:  Stephanie L Rogers; Elyse Rankin-Gee; Rashmi M Risbud; Brenda E Porter; Eric D Marsh
Journal:  Neuroscience       Date:  2018-06-07       Impact factor: 3.590

5.  Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia.

Authors:  Danko Georgiev; Dominique Arion; John F Enwright; Mitsuru Kikuchi; Yoshio Minabe; John P Corradi; David A Lewis; Takanori Hashimoto
Journal:  Am J Psychiatry       Date:  2014-01       Impact factor: 18.112

Review 6.  Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.

Authors:  Hirofumi Morishita; Marija Kundakovic; Lucy Bicks; Amanda Mitchell; Schahram Akbarian
Journal:  Neurobiol Learn Mem       Date:  2015-04-04       Impact factor: 2.877

Review 7.  Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Authors:  Sabina Berretta; Stephan Heckers; Francine M Benes
Journal:  Schizophr Res       Date:  2014-11-11       Impact factor: 4.939

Review 8.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

Review 9.  Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights.

Authors:  Venkat Raghavan Krishnaswamy; Amit Benbenishty; Pablo Blinder; Irit Sagi
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

10.  Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.

Authors:  Matej Markota; Jessica Sin; Harry Pantazopoulos; Rebecca Jonilionis; Sabina Berretta
Journal:  Schizophr Bull       Date:  2014-06-16       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.